ARCHIVES

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

This article is from The Cancer Letter archive.

Vol. 37 No. 44 | December 2, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Offers Chlorozotocin

November 18, 1977

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

February 27, 1987

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

June 4, 1993

Group Chairmen Cool To New Groups, Told Their Remarks Are Inappropriate

July 21, 1978

DCPC Board Approves New Intramural Laboratory for Diet And Nutrition; NCAB to Consider It Next

May 22, 1987

Recommendation By Patients; report Of Protocol Committee

August 9, 1996